160 related articles for article (PubMed ID: 4831431)
1. Editorial: Immune surveillance revisited.
Kripke ML; Borsos T
J Natl Cancer Inst; 1974 May; 52(5):1393-5. PubMed ID: 4831431
[No Abstract] [Full Text] [Related]
2. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
3. Malignant disease in immunodeficient states in man.
Penn I
Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
[No Abstract] [Full Text] [Related]
4. Immunodeficiency and cancer.
Kersey JH; Spector BD; Good RA
Adv Cancer Res; 1973; 18():211-30. PubMed ID: 4148723
[No Abstract] [Full Text] [Related]
5. Letter: Immune surveillance revisited.
Law LW
J Natl Cancer Inst; 1975 Jan; 54(1):280-2. PubMed ID: 1113309
[No Abstract] [Full Text] [Related]
6. Occurrence of cancer in immune deficiencies.
Penn I
Cancer; 1974 Sep; 34(3):suppl:858-66. PubMed ID: 4853422
[No Abstract] [Full Text] [Related]
7. Tumour development following immunosuppression.
Allison AC
Proc R Soc Med; 1970 Oct; 63(10):1077-80. PubMed ID: 4320709
[No Abstract] [Full Text] [Related]
8. Immunosuppression and oncogenic virus infections.
Hirsch MS; Black PH; Proffitt MR
Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
[No Abstract] [Full Text] [Related]
9. Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
Pilch YH; Myers GH; Sparks FC; Golub SH
Curr Probl Surg; 1975 Jan; ():1-46. PubMed ID: 236150
[No Abstract] [Full Text] [Related]
10. Immunodepression and malignancy.
Stutman O
Adv Cancer Res; 1975; 22():261-422. PubMed ID: 766581
[No Abstract] [Full Text] [Related]
11. [The immunology of cancer].
Tabbara WS
J Med Liban; 1971; 24(3):209-26. PubMed ID: 5151404
[No Abstract] [Full Text] [Related]
12. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
Cerilli J; Hattan D
Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
[No Abstract] [Full Text] [Related]
13. [Immunosuppression, genesis and growth of malignant tumours].
Reis HE
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(1):42-50. PubMed ID: 4264377
[No Abstract] [Full Text] [Related]
14. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G
Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
[No Abstract] [Full Text] [Related]
15. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
Wagner JL; Haughton G
J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
[No Abstract] [Full Text] [Related]
16. A new horizon in cancer therapy: Immunotherapy. II.
Thompson RB
J Miss State Med Assoc; 1972 Jan; 13(1):10-3. PubMed ID: 4550110
[No Abstract] [Full Text] [Related]
17. Editorial: Cancer immunotherapy.
Hussey HH
JAMA; 1974 Jan; 227(4):435. PubMed ID: 4543616
[No Abstract] [Full Text] [Related]
18. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
19. [Immune reaction of autochthonous tumor--analysis of cellular immunity in rejection of methylcholanthrene-induced autochthonous tumor].
Kikuchi K; Kikuchi Y
Saishin Igaku; 1971 Nov; 26(11):2170-9. PubMed ID: 5141954
[No Abstract] [Full Text] [Related]
20. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
